30th Jan 2006 07:01
Bespak PLC30 January 2006 For immediate release 30 January 2006 Bespak plc Welcomes regulatory approval of Exubera(R) in the United States Bespak plc (LSE: BPK), a leader in specialty medical devices, is pleased to notethat Pfizer Inc announced on Friday evening, 27 January 2006, that the UnitedStates Food and Drug Administration (FDA) has approved Exubera (inhaled humaninsulin) for the treatment of adults with type 1 and type 2 diabetes. Thisfollows approval by the European Commission last Thursday. Exubera, which is expected to be available for patients by mid-year, is thefirst inhaled form of insulin and the first insulin option that does not need tobe administered by injection in the United States. Bespak, in conjunction with Nektar Therapeutics, has developed the manufacturingprocess for Exubera's inhaler, which the Company will manufacture at its purposedesigned facility in Milton Keynes. The inhaler produces in its chamber a cloudof insulin powder, which is designed to pass rapidly into the bloodstream toregulate the body's blood sugar levels. Mark Throdahl, Bespak's Chief Executive, said: "We are delighted that both theUS and European filings have been approved and we look forward to participatingin the commercial success of Exubera by supplying the inhaler device." For further information please call: Bespak plcMark Throdahl - Chief Executive +44 (0) 20 1908 552 600Martin Hopcroft - Group Finance Director Buchanan Communications +44 (0) 20 7466 5000Tim Thompson / Mark Court / Mary-Jane Johnson Notes for Editors: About Bespak plc Bespak, a leader in specialty medical devices, develops delivery systems for thepharmaceutical industry and disposable airway management products for criticalcare settings. Bespak's product range includes metered dose and dry powderinhalers, actuators, inflation valves, disposable face masks, breathing circuitsand laryngeal tubes. The group, which has facilities in King's Lynn and MiltonKeynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on theOfficial List of the London Stock Exchange (LSE: BPK). For more information,please visit www.bespak.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L